83 related articles for article (PubMed ID: 19837166)
41. Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system.
Banares S; Zeh K; Krajewska M; Kermer P; Baribault H; Reed JC; Krajewski S
Genesis; 2005 May; 42(1):6-16. PubMed ID: 15828007
[TBL] [Abstract][Full Text] [Related]
42. Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance.
Asano T; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):227-232. PubMed ID: 34678093
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal antibodies specific for podocalyxin expressed on human induced pluripotent stem cells.
Watanabe T; Kakuta J; Saito S; Hasehira K; Kiyoi K; Imai T; Tateno H
Biochem Biophys Res Commun; 2020 Nov; 532(4):647-654. PubMed ID: 32912628
[TBL] [Abstract][Full Text] [Related]
44. Somatic ablation of the Lrat gene in the mouse retinal pigment epithelium drastically reduces its retinoid storage.
Ruiz A; Ghyselinck NB; Mata N; Nusinowitz S; Lloyd M; Dennefeld C; Chambon P; Bok D
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5377-87. PubMed ID: 18055784
[TBL] [Abstract][Full Text] [Related]
45. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
Schopperle WM; DeWolf WC
Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
[TBL] [Abstract][Full Text] [Related]
46. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
47. Leukocyte-endothelial cell interaction is enhanced in podocalyxin-deficient mice.
Porras G; Ayuso MS; González-Manchón C
Int J Biochem Cell Biol; 2018 Jun; 99():72-79. PubMed ID: 29604348
[TBL] [Abstract][Full Text] [Related]
48. Podocalyxin in Normal Tissue and Epithelial Cancer.
Le Tran N; Wang Y; Nie G
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
[TBL] [Abstract][Full Text] [Related]
49. Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat.
Testa JE; Chrastina A; Li Y; Oh P; Schnitzer JE
J Vasc Res; 2009; 46(4):311-24. PubMed ID: 19142011
[TBL] [Abstract][Full Text] [Related]
50. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.
Le Tran N; Wang Y; Bilandzic M; Stephens A; Nie G
Sci Rep; 2024 Mar; 14(1):7539. PubMed ID: 38553472
[TBL] [Abstract][Full Text] [Related]
51. Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site.
Amo L; Díez-García J; Tamayo-Orbegozo E; Maruri N; Larrucea S
Front Immunol; 2022; 13():835527. PubMed ID: 35711462
[TBL] [Abstract][Full Text] [Related]
52. Role of CD34 family members in lumen formation in the developing kidney.
Yang Z; Zimmerman SE; Tsunezumi J; Braitsch C; Trent C; Bryant DM; Cleaver O; González-Manchón C; Marciano DK
Dev Biol; 2016 Oct; 418(1):66-74. PubMed ID: 27542690
[TBL] [Abstract][Full Text] [Related]
53. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function.
Román-Fernández A; Mansour MA; Kugeratski FG; Anand J; Sandilands E; Galbraith L; Rakovic K; Freckmann EC; Cumming EM; Park J; Nikolatou K; Lilla S; Shaw R; Strachan D; Mason S; Patel R; McGarry L; Katoch A; Campbell KJ; Nixon C; Miller CJ; Leung HY; Le Quesne J; Norman JC; Zanivan S; Blyth K; Bryant DM
Sci Adv; 2023 Feb; 9(5):eabq1858. PubMed ID: 36735782
[TBL] [Abstract][Full Text] [Related]
54. Podocalyxin-Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway.
Chen WJ; Huang WK; Pather SR; Chang WF; Sung LY; Wu HC; Liao MY; Lee CC; Wu HH; Wu CY; Liao KS; Lin CY; Yang SC; Lin H; Lai PL; Ng CH; Hu CM; Chen IC; Chuang CH; Lai CY; Lin PY; Lee YC; Schuyler SC; Schambach A; Lu FL; Lu J
Adv Sci (Weinh); 2022 Nov; 10(1):e2205451. PubMed ID: 36373710
[TBL] [Abstract][Full Text] [Related]
55. [Slp2-a transports the apical signaling molecule podocalyxin to the apical surface and affects cell-cell interactions].
Yasuda T; Fukuda M
Seikagaku; 2013 Feb; 85(2):106-10. PubMed ID: 23539965
[No Abstract] [Full Text] [Related]
56. Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models.
Canals Hernaez D; Hughes MR; Li Y; Mainero Rocca I; Dean P; Brassard J; Bell EM; Samudio I; Mes-Masson AM; Narimatsu Y; Clausen H; Blixt O; Roskelley CD; McNagny KM
Front Oncol; 2022; 12():856424. PubMed ID: 35600398
[TBL] [Abstract][Full Text] [Related]
57. Atypical focal segmental glomerulosclerosis associated with a new PODXL nonsense variant.
Marx D; Caillard S; Olagne J; Moulin B; Hannedouche T; Touchard G; Dupuis A; Gachet C; Molitor A; Bahram S; Carapito R
Mol Genet Genomic Med; 2021 May; 9(5):e1658. PubMed ID: 33780168
[TBL] [Abstract][Full Text] [Related]
58. Effect of Cell Spreading on Rosette Formation by Human Pluripotent Stem Cell-Derived Neural Progenitor Cells.
Townshend RF; Shao Y; Wang S; Cortez CL; Esfahani SN; Spence JR; O'Shea KS; Fu J; Gumucio DL; Taniguchi K
Front Cell Dev Biol; 2020; 8():588941. PubMed ID: 33178701
[TBL] [Abstract][Full Text] [Related]
59. Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage.
Fernández-Muñoz B; Rosell-Valle C; Ferrari D; Alba-Amador J; Montiel MÁ; Campos-Cuerva R; Lopez-Navas L; Muñoz-Escalona M; Martín-López M; Profico DC; Blanco MF; Giorgetti A; González-Muñoz E; Márquez-Rivas J; Sanchez-Pernaute R
Stem Cells Transl Med; 2020 Sep; 9(9):1085-1101. PubMed ID: 32475061
[TBL] [Abstract][Full Text] [Related]
60. Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome.
Kang HG; Lee M; Lee KB; Hughes M; Kwon BS; Lee S; McNagny KM; Ahn YH; Ko JM; Ha IS; Choi M; Cheong HI
Exp Mol Med; 2017 Dec; 49(12):e414. PubMed ID: 29244787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
